![]() |
|
|
Moody's: Enhanced FDA Scrutiny Could Pressure Device MakersJohnson & Johnson, Boston Scientific appear to be most vulnerable to the increased scrutiny Boston Scientific Loses Bid for New Patent TrialCompany plans to appeal ruling |
| Copyright © 2008 • Rodman Publishing • Privacy Policy |